Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:EARS
Delisted

Auris Medical Holding AG Stock Price (Quote)

$0.750
-0.0010 (-0.133%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $0.680 $1.00 Friday, 27th May 2022 EARS stock ended at $0.750. This is 0.133% less than the trading day before Thursday, 26th May 2022. During the day the stock fluctuated 10.68% from a day low at $0.740 to a day high of $0.82.
90 days $0.635 $2.14
52 weeks $0.635 $4.58

Historical Auris Medical Holding AG prices

Date Open High Low Close Volume
Apr 05, 2016 $3.68 $3.83 $3.65 $3.68 49 310
Apr 04, 2016 $3.63 $3.83 $3.55 $3.67 117 964
Apr 01, 2016 $3.61 $3.72 $3.52 $3.61 64 947
Mar 31, 2016 $3.55 $3.72 $3.55 $3.64 138 265
Mar 30, 2016 $3.41 $3.67 $3.37 $3.51 108 854
Mar 29, 2016 $3.38 $3.40 $3.20 $3.36 107 200
Mar 28, 2016 $3.45 $3.53 $3.25 $3.38 78 800
Mar 24, 2016 $3.50 $3.58 $3.28 $3.43 96 300
Mar 23, 2016 $3.78 $3.82 $3.56 $3.56 125 100
Mar 22, 2016 $3.83 $3.91 $3.70 $3.81 120 700
Mar 21, 2016 $3.78 $3.92 $3.70 $3.82 69 000
Mar 18, 2016 $3.86 $3.95 $3.72 $3.75 121 100
Mar 17, 2016 $4.01 $4.04 $3.80 $3.83 125 500
Mar 16, 2016 $4.44 $4.44 $3.90 $4.00 365 600
Mar 15, 2016 $4.84 $4.84 $4.39 $4.47 118 500
Mar 14, 2016 $4.60 $4.81 $4.51 $4.79 208 700
Mar 11, 2016 $4.48 $4.62 $4.37 $4.51 112 200
Mar 10, 2016 $4.56 $4.58 $4.25 $4.40 129 100
Mar 09, 2016 $4.58 $4.65 $4.50 $4.56 91 600
Mar 08, 2016 $4.73 $4.94 $4.50 $4.58 136 300
Mar 07, 2016 $4.45 $4.79 $4.42 $4.70 85 500
Mar 04, 2016 $4.58 $4.62 $4.43 $4.50 203 800
Mar 03, 2016 $4.66 $4.77 $4.41 $4.58 282 800
Mar 02, 2016 $4.72 $4.83 $4.50 $4.65 346 800
Mar 01, 2016 $4.74 $4.79 $4.35 $4.69 516 800
Click to get the best stock tips daily for free!

About Auris Medical Holding AG

Auris Medical Holding AG Auris Medical Holding AG, a clinical-stage biopharmaceutical company, focuses on the development of novel products for the treatment of inner ear disorders. Its lead product candidate includes AM-101, which is in Phase III clinical development for treating acute inner ear tinnitus. The company is also developing AM-111 for the treatment of acute sensorineural hearing loss; and other pre-clinical stage products comprising AM-102 and AM-123. It has... EARS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT